Central compartment of nasal cavity-derived MMP-9 enhances mixed-type 2 inflammation in eosinophilic chronic rhinosinusitis
International Immunology · 2025
DOI: 10.1093/intimm/dxaf025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2025. Verfasst von Takeshi Tsuda und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, The University of Osaka Graduate School of Medicine Faculty of Medicine, 2-2 Yamadaoka, Suit…. Hauptthemen laut MEDLINE: Sinusitis, Matrix Metalloproteinase 9, Rhinitis, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: MEXT/JPS KAKENHI.
Abstract (Originalsprache)
Chronic rhinosinusitis (CRS) is an inflammatory disease of the upper respiratory tract. Although previously classified based on the presence or absence of nasal polyps, it is now commonly classified by endotype. Eosinophilic CRS (ECRS) is based on type 2 inflammation and the formation of intractable nasal polyps with eosinophil infiltration. Endoscopic surgery is the preferred treatment modality; however, recurrent cases are common. The central compartment of the nasal cavity has been implicated in these recurrences. Notably, the middle turbinate is considered crucial, but discussions have primarily focused on its anatomical significance. To date, there lacks a biochemical perspective on the role of the middle turbinate in recurrence. In this study, we evaluated the role of the middle turbinate as a source of inflammation in ECRS. Differences in gene expression between ECRS and non-ECRS (NECRS) middle turbinates were evaluated using RNA sequencing. Gene changes induced by MMP-9 stimulation of human nasal epithelial cells were also evaluated by RNA sequencing. Comprehensive analysis showed an enhanced IL-4 signaling pathway in the ECRS middle turbinate. Additionally, gene expression of matrix metalloproteinase-9 (MMP-9) was higher in the middle turbinates of patients with ECRS than in those with NECRS (P = .002). Furthermore, MMP-9 has been found to act on human nasal epithelial cells to enhance pathways such as IL-17, IL-6, and S100 family signaling. MMP-9 in the central compartment of the nasal cavity exacerbates ECRS by induction mixed-type 2 inflammation and airway remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, The University of Osaka Graduate School of Medicine Faculty of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Department of Otorhinolaryngology, Hyogo Prefectural Nishinomiya Hospital, 13-9 Rokutanji-cho, Nishinomiya, Hyogo 662-0918, Japan.
- Department of Otorhinolaryngology, Japan Community Healthcare Organization Osaka Hospital, 4-2-78 Fukushima, Fukushima-ku, Osaka 553-0003,Japan.
- Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, The University of Osaka, Suita, Osaka, Japan.
- Laboratory of Human Immunology (Single Cell Genomics), WPI Immunology Frontier Research Center, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Department of Pathology, The University of Osaka Graduate School of Medicine Faculty of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Yukinori Takenaka, Daisuke Okuzaki
Förderung
- MEXT/JPS KAKENHI
Zitieren
APA
Tsuda, T., Fujii, S., Obata, S., Takeda, K., Hayama, M., Maeda, Y., Nakatani, A., Umeda, N., Saito, M., Fujii, K., Kishikawa, T., Tanaka, H., Hosokawa, K., Sato, T., Takenaka, Y., Okuzaki, D., Nojima, S., Ishii, M., & Inohara, H. (2025). Central compartment of nasal cavity-derived MMP-9 enhances mixed-type 2 inflammation in eosinophilic chronic rhinosinusitis. International Immunology. https://doi.org/10.1093/intimm/dxaf025
Vancouver
Tsuda T, Fujii S, Obata S, Takeda K, Hayama M, Maeda Y, et al. Central compartment of nasal cavity-derived MMP-9 enhances mixed-type 2 inflammation in eosinophilic chronic rhinosinusitis. International Immunology. 2025. doi:10.1093/intimm/dxaf025
BibTeX
@article{Tsuda2025,
author = {Tsuda, Takeshi and Fujii, Soichiro and Obata, Sho and Takeda, Kazuya and Hayama, Masaki and Maeda, Yohei and Nakatani, Ayaka and Umeda, Naoki and Saito, Miyu and Fujii, Kentaro and Kishikawa, Toshihiro and Tanaka, Hidenori and Hosokawa, Kiyohito and Sato, Takashi and Takenaka, Yukinori and Okuzaki, Daisuke and Nojima, Satoshi and Ishii, Masaru and Inohara, Hidenori},
title = {Central compartment of nasal cavity-derived MMP-9 enhances mixed-type 2 inflammation in eosinophilic chronic rhinosinusitis},
journal = {International Immunology},
year = {2025},
doi = {10.1093/intimm/dxaf025}
}
EUVIMED